02.17.15
Ortho-Clinical Diagnostics Inc. has obtained CE Mark for its Ortho Vision Analyzer, a highly interactive, fully automated analyzer for transfusion medicine laboratories.
Transfusion medicine has evolved to enhance safety and establish critical efficiencies, although current automation solutions lack the ability to anticipate and respond to individual user needs and ever-changing conditions within the laboratory. The introduction of the Ortho Vision Analyzer represents a system able to meet these needs through automation that is responsive, the next evolution in transfusion medicine, the company claims.
“The Ortho Vision Analyzer’s pairing of secure monitoring technologies and dynamic work flow management is an advance that offers labs the ability to address unpredictable demands when needed and have confidence in the results,” said Robert Yates, Ortho Clinical Diagnostics chief operating officer. “With the launch of the Ortho Vision Analyzer and responsive automation, our goal is to greatly improve the safety of blood transfusions by reducing the lab’s reliance on manual methods.”
Designed with secure monitoring technologies for responsive safety checks and balances, the Ortho Vision Analyzer gives transfusion medicine professionals the ability to track every critical automated step in the immunohematology testing process. Through Ortho Clinical Diagnostics’ proprietary IntelliCheck Technology, the analyzer verifies and documents diagnostic checks throughout the sampling process while e-Connectivity provides 24/7 remote data tracking that monitors and ensures instrument performance while maximizing uptime. Laboratory personnel also can log on anytime, anywhere to collaborate on interpreting results in real time.
In addition to multiple safety advancements, the analyzer also delivers dynamic workflow management, providing the adaptability to respond to unpredictable lab demand, the company noted in a news release. Now lab personnel will be able to focus on prioritizing tests as they are requested, including STAT requests, making informed decisions and re-establishing a natural flow in the lab, all while automating more tests than currently possible.
Based in Raritan, N.J., Ortho-Clinical Diagnostics develops and markets solutions for screening, diagnosing, monitoring and confirming disease.
Transfusion medicine has evolved to enhance safety and establish critical efficiencies, although current automation solutions lack the ability to anticipate and respond to individual user needs and ever-changing conditions within the laboratory. The introduction of the Ortho Vision Analyzer represents a system able to meet these needs through automation that is responsive, the next evolution in transfusion medicine, the company claims.
“The Ortho Vision Analyzer’s pairing of secure monitoring technologies and dynamic work flow management is an advance that offers labs the ability to address unpredictable demands when needed and have confidence in the results,” said Robert Yates, Ortho Clinical Diagnostics chief operating officer. “With the launch of the Ortho Vision Analyzer and responsive automation, our goal is to greatly improve the safety of blood transfusions by reducing the lab’s reliance on manual methods.”
Designed with secure monitoring technologies for responsive safety checks and balances, the Ortho Vision Analyzer gives transfusion medicine professionals the ability to track every critical automated step in the immunohematology testing process. Through Ortho Clinical Diagnostics’ proprietary IntelliCheck Technology, the analyzer verifies and documents diagnostic checks throughout the sampling process while e-Connectivity provides 24/7 remote data tracking that monitors and ensures instrument performance while maximizing uptime. Laboratory personnel also can log on anytime, anywhere to collaborate on interpreting results in real time.
In addition to multiple safety advancements, the analyzer also delivers dynamic workflow management, providing the adaptability to respond to unpredictable lab demand, the company noted in a news release. Now lab personnel will be able to focus on prioritizing tests as they are requested, including STAT requests, making informed decisions and re-establishing a natural flow in the lab, all while automating more tests than currently possible.
Based in Raritan, N.J., Ortho-Clinical Diagnostics develops and markets solutions for screening, diagnosing, monitoring and confirming disease.